BioAsia 2023: Leaders from Novartis, Apple Talk Innovation, Tech, Data Privacy

BioAsia 2023 was a melting pot of ideas with Novartis's CEO and a senior executive from Apple, among others, discussing a range of topics including the potential of novel therapies and platforms such as siRNA and radioligand and also where things were headed as the union of technology and biotech drives new insights into biology and promises to help reimagine healthcare.

Tech, Biotech confluence discussed at BioAsia

More from Business

More from Scrip